The 2001 Bethesda System: terminology for reporting results of cervical cytology.

By D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'connor, M. Prey, S. Raab, M. Sherman, D. Wilbur, T. Wright and 1 more. Journal of the American Medical Association (JAMA), 2002

3,434 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/964abd013290427487c3af27b91e503f3c29bedc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Luisa Lina Villa
2. Mark Schiffman
3. E. Burd
4. M. Stanley

In Oncology

1. E. Burd

Citations in the corpus

• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up (2006, background): “…of genital wart cases (Wiley et al, 2002) and recurrent respiratory papillomatosis, an aggressive, highly morbid and occasionally fatal disease manifested as rapidly growing benign laryngeal tumours that cause airway obstruction (Somers et al, 1997; Derkay and Darrow, 2000; Green et al, 2000).”
• 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. (2013, methodology): “For cytologic classification and assessment of cytology specimen adequacy, the 2001 Bethesda System was used (1).”